ArticleNeurogastroenterology and motility2026
Percutaneous Electrical Nerve Field Stimulation Improves Weight and Other Anthropometric Outcomes in Children and Adolescents With Functional Dyspepsia Who Restrict Their Oral Intake.
Article in Neurogastroenterology and motility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Composite fiber remodels gut microbiota and shows a trend of alleviating dyspepsia in adolescents with functional dyspepsia: a 16S rRNA pilot study.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFunctional dyspepsia (FD), a disorder of the gut-brain interaction (DGBI), can result in restricted eating habits with associated weight loss. Percutaneous Electrical Nerve Field Stimulation (PENFS), a minimally invasive non-pharmacologic approach, can improve abdominal pain and psychological functioning in children with DGBI. We aimed to analyze changes in anthropometric measures, nutritional intake, and clinical outcomes with PENFS.
methodsWe retrospectively reviewed charts of patients with FD (9-28 years) who restricted oral intake and underwent PENFS. We analyzed validated questionnaires used during treatment. Anthropometric data were also assessed during and after 3 months of treatment. Results were analyzed through linear mixed modeling as least square means. KEY
resultsNinety patients reported restricted oral intake, 42% had baseline weight loss and 13% requiring enteral support. Oral intake (p = 0.001), weight (p = 0.02) and BMI (p = 0.002) significantly increased after PENFS. Abdominal pain, nausea, functional disability, depression, and somatization also improved after PENFS. Increased weight Z scores were associated with lower nausea, pain catastrophizing, and depression. CONCLUSIONS AND INFERENCES: PENFS improved oral intake, weight, and other anthropometric measures in addition to GI and psychological measures in patients with FD. Changes in anthropometrics were sustained at 3-month follow up. PENFS may be an effective treatment for patients with FD, including children, and restrictive eating to optimize nutritional outcomes. Future studies should include prospective clinical trials and investigate the mechanism of action of PENFS on eating habits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.